BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17564430)

  • 1. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
    Han D; Wang H; Yang P
    Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
    Faller P
    Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
    Hou L; Zagorski MG
    J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide.
    Suzuki K; Miura T; Takeuchi H
    Biochem Biophys Res Commun; 2001 Jul; 285(4):991-6. PubMed ID: 11467850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Abeta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy.
    Chen YR; Huang HB; Chyan CL; Shiao MS; Lin TH; Chen YC
    J Biochem; 2006 Apr; 139(4):733-40. PubMed ID: 16672274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
    Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
    Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations.
    Lemkul JA; Bevan DR
    Biochemistry; 2010 May; 49(18):3935-46. PubMed ID: 20369844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
    Milojevic J; Esposito V; Das R; Melacini G
    J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.
    Karr JW; Kaupp LJ; Szalai VA
    J Am Chem Soc; 2004 Oct; 126(41):13534-8. PubMed ID: 15479110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics study of the beta amyloid peptide of Alzheimer's disease and its divalent copper complexes.
    Raffa DF; Rauk A
    J Phys Chem B; 2007 Apr; 111(14):3789-99. PubMed ID: 17388547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the alpha-helix to beta-hairpin transition mechanism and the formation of oligomeric aggregates of the fibrillogenic peptide Abeta(12-28): insights from all-atom molecular dynamics simulations.
    Simona F; Tiana G; Broglia RA; Colombo G
    J Mol Graph Model; 2004 Dec; 23(3):263-73. PubMed ID: 15530822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular dynamics approach to the structural characterization of amyloid aggregation.
    Cecchini M; Curcio R; Pappalardo M; Melki R; Caflisch A
    J Mol Biol; 2006 Apr; 357(4):1306-21. PubMed ID: 16483608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
    Faller P; Hureau C
    Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
    Karr JW; Szalai VA
    Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface.
    Ryu J; Girigoswami K; Ha C; Ku SH; Park CB
    Biochemistry; 2008 May; 47(19):5328-35. PubMed ID: 18422346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.